News & Press: Latest News

MDMA Statement on House Device Tax Repeal Bill Securing 218 Co-Sponsors

Tuesday, April 9, 2013  
Share |

WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the 218th co-sponsor of H.R. 523, the "Protect Medical Innovation Act of 2013,” providing the bill enough support to pass the U.S. House of Representatives:

"This important milestone for repealing the medical device tax is another strong signal that there is overwhelming bipartisan support in Congress to put an end to this bad policy.  On the heels of the Senate’s message that repeal is a priority for them as well, we encourage Congress to move as soon as possible so that the medical device community can continue to fulfill its mission to improve patient care and alleviate human suffering.

"Our fragile economy can’t afford policies that stifle job creation, and repealing the medical device tax will be a shot in the arm for American high-tech manufacturing at a time when our workforce needs it.”